𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinct Experimental Efficacy of Anti-Fas/APO-1/CD95 Receptor Antibody in Human Tumors

✍ Scribed by Didier Decaudin; Arnaud Beurdeley-Thomas; Fariba Nemati; Laurent Miccoli; Pierre Pouillart; Yveline Bourgeois; Rui Bras Gonçalves; Dany Rouillard; Marie-France Poupon

Book ID
115604066
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
128 KB
Volume
268
Category
Article
ISSN
0014-4827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sensitivity of Epstein-Barr virus-induce
Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody
✍ Anne Durandy; Françoise Le Deist; Jean-François Emile; Klaus Debatin; Alain Fisc 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Epstein-Barr virus (EBV) can induce uncontrolled B lymphocyte proliferation leading to fatal lymphoma in immunocompromised patients. The sensitivity to apoptosis of B lymphoid cell lines (LCL) derived from EBV-induced lymphoproliferative disorders was investigated. In vitro and in vivo, these B LCL

Hypermethylation of the tumor necrosis f
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor κB sites in prostatic carcinoma
✍ Simon Santourlidis; Ulrich Warskulat; Andrea R. Florl; Simone Maas; Thomas Pulte 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

DNA hypermethylation of CpG-rich promoter sequences is associated with tumor suppressor gene inactivation in many human cancers, notably in carcinoma of the prostate and the urinary bladder. Recently, the mouse homologue of the tumor necrosis factor receptor superfamily 6 (TNFRSF6) gene was reported